grant

Oral fenofibrate therapy to retard Chronic Kidney Disease in Type 2 diabetes

Also known as: Clinical Trials and Cohort Studies

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/2024025]

Funding Amount $5,736,695.64

Full description Kidney disease is a major cause of illness and death in people with diabetes. A low-cost, well-tolerated drug, fenofibrate, appears to reduce kidney protein leak and protect kidneys from further damage. This trial, enrolling patients across Australia, New Zealand and Asia (Malaysia, Hong Kong and Vietnam) aims to confirm our preliminary findings as to whether this treatment can delay late-stage kidney failure (which may require dialysis, kidney transplantation or cause death).

Chief Investigator Prof Alicia Jenkins

Date Announced 2023-07-31T00:00:00

Sector University

Click to explore relationships graph

Spatial Coverage And Location

text: NSW

Identifiers
Viewed: [[ro.stat.viewed]]